| Karla E Khan, MD | |
|
235 E Rowan Ave, Ste 102, Spokane, WA 99207-1240 | |
| (509) 489-2101 | |
| (509) 462-4949 |
| Full Name | Karla E Khan |
|---|---|
| Gender | Female |
| Speciality | Obstetrics & Gynecology |
| Location | 235 E Rowan Ave, Spokane, Washington |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003812678 | NPI | - | NPPES |
| 8246430 | Medicaid | WA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | MD00038086 (Washington) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Karla E Khan, MD 235 E Rowan Ave, Ste 102, Spokane, WA 99207-1240 Ph: (509) 489-2101 | Karla E Khan, MD 235 E Rowan Ave, Ste 102, Spokane, WA 99207-1240 Ph: (509) 489-2101 |
News Archive
News outlets report that this kind of status is leading some Medicare beneficiaries to be surprised by the size of hospital bills because, ultimately, the services they received were not classified as inpatient care.
Researchers from the street medicine team at the Keck School of Medicine of USC have developed "HOUSED BEDS," the first published tool designed specifically to help outreach teams clearly assess the situation of unsheltered homeless patients
Fetal Alcohol Research, the official journal of FACE, has published breakthrough research by Dr. Sterling Clarren, CEO and Chief Scientific Officer of Canada Northwest FASD Research Network and colleagues, establishing Canadian norms which will allow more accurate diagnosis of Fetal Alcohol Spectrum Disorder (FASD).
Eleven Biotherapeutics, a biopharmaceutical company focused on translating breakthrough discoveries from science and medicine to engineer and develop innovative protein-based therapeutics, today announced the receipt of three grants totaling more than $733,000 from the Qualifying Therapeutic Discovery Project (QTDP) Program.
Trius Therapeutics, Inc. announced today the issuance of Patent Number 7,816,379, entitled "Oxazolidinone Derivatives," by the United States Patent and Trademark Office (USPTO). The new patent, which is exclusively licensed to Trius, protects the Company's lead investigational drug, torezolid phosphate (TR-701), currently in Phase 3 clinical testing in patients with acute bacterial skin and skin structure infections (ABSSSI).
› Verified 4 days ago
Dr. Craig M. Smentek, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 32 W 2nd Ave, Spokane, WA 99201 Phone: 509-626-9825 Fax: 509-227-7070 | |
Casey Hay, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 101 W 8th Ave Ste 1400, Spokane, WA 99204 Phone: 509-474-2200 Fax: 509-474-2737 | |
Dr. Dawn Michelle Kopp, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 101 W 8th Ave Ste 1100, Spokane, WA 99204 Phone: 509-474-4060 Fax: 509-227-7070 | |
Kristian Enghusen, OMS IV Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 322 W North River Dr, Spokane, WA 99201 Phone: 509-324-6464 Fax: 509-241-2056 | |
Dr. Abigail Rose Prest, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 212 E Central Ave Ste 340, Spokane, WA 99208 Phone: 509-484-1236 | |
Mr. Robert F Sestero, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 820 S Mcclellan St, #116, Spokane, WA 99204 Phone: 509-838-4211 Fax: 509-838-6432 |